Trade IMNM stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Immunome, Inc. (IMNM) is trading at US$26.36, down 1.68% today as of Sep 9, 14:21 EDT. The company has a market capitalisation of US$3.24B. Over the past 52 weeks, IMNM has traded between US$8.93 and US$30.06. On Syfe you can trade IMNM with $0 commission and add it to your watchlist.
| Previous close | US$26.81 |
|---|---|
| Market cap | US$3.24B |
| 52-week range | US$8.93 – US$30.06 |
| Volume | 827.72K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Immunome, Inc.
Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. It also focuses on oncology and infectious disease areas. The company was founded by Scott K. Dessain and Gregory P. Licholai on March 2, 2006 and is headquartered in Bothell, WA.
Year: 2020
Immunome Begins Phase 1 Trial Dosing of Therapy for Advanced Solid Tumors
Jul 20, 12:14 PM · MT Newswires
Immunome Says FDA Accepted NDA for Desmoid Tumors Drug
Jul 8, 12:06 PM · MT Newswires
Immunome Insider Sold Shares Worth $2,412,522, According to a Recent SEC Filing
Jul 8, 7:34 AM · MT Newswires
Immunome Insider Sold Shares Worth $1,244,331, According to a Recent SEC Filing
Jul 7, 9:47 PM · MT Newswires
Immunome, Inc. (IMNM) stock is trading at US$26.36, -1.68% from the previous close of US$26.81.
The market cap for Immunome, Inc. (IMNM) stock is approximately US$3.24B.
The 52-week high for Immunome, Inc. (IMNM) stock is US$30.06.
The 52-week low for Immunome, Inc. (IMNM) stock is US$8.93.
Immunome, Inc. (IMNM) does not currently pay a dividend.
Stay on top of IMNM
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
